Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.

MLA

Rozovski, Uri, et al. “Ibrutinib Inhibits Free Fatty Acid Metabolism in Chronic Lymphocytic Leukemia.” Leukemia & Lymphoma, vol. 59, no. 11, Nov. 2018, pp. 2686–91. EBSCOhost, https://doi.org/10.1080/10428194.2018.1439167.

APA

Rozovski, U., Harris, D. M., Li, P., Liu, Z., Jain, P., Ferrajoli, A., Burger, J., Thompson, P., Jain, N., Wierda, W., Keating, M. J., & Estrov, Z. (2018). Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia. Leukemia & Lymphoma, 59(11), 2686–2691. https://doi.org/10.1080/10428194.2018.1439167

Chicago

Rozovski, Uri, David M Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan Burger, et al. 2018. “Ibrutinib Inhibits Free Fatty Acid Metabolism in Chronic Lymphocytic Leukemia.” Leukemia & Lymphoma 59 (11): 2686–91. doi:10.1080/10428194.2018.1439167.